What Happened?
Shares of health insurance company Clover Health (NASDAQ: CLOV) fell 4.8% in the afternoon session after a filing revealed that the company's CEO, Wai Conrad, sold a portion of his holdings. According to a regulatory filing on July 11, 2025, CEO Wai Conrad sold 15,203 shares of Class A Common Stock on July 8 for a total of approximately $49,561. The transactions were made at prices ranging from $3.25 to $3.27 per share.
While the sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell a predetermined number of shares at a predetermined time, the news can still create unease among investors. Insider selling, even when planned, is often scrutinized by the market for any signals about a company's future prospects, contributing to negative pressure on the stock price.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Clover Health? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Clover Health’s shares are extremely volatile and have had 45 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
Clover Health is down 7.2% since the beginning of the year, and at $2.91 per share, it is trading 39.7% below its 52-week high of $4.82 from January 2025. Investors who bought $1,000 worth of Clover Health’s shares 5 years ago would now be looking at an investment worth $261.71.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.
